Ignite Creation Date:
2025-12-24 @ 1:35 PM
Ignite Modification Date:
2026-01-26 @ 3:46 PM
Study NCT ID:
NCT04170595
Status:
UNKNOWN
Last Update Posted:
2021-03-03
First Post:
2019-11-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection
Sponsor:
Genor Biopharma Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | HER2-positive Breast Cancer | View |
Keywords: